Clinical Trial Update: Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial targeting central pulsatile hemodynamics in chronic kidney disease was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Insufficiency Chronic

Snippet

Sponsor: University of Pennsylvania | Conditions: Renal Insufficiency, Chronic | Phase 2 | Status: TERMINATED | Results posted: 2020-08-13